Morgan Stanley’s Co-Head of Healthcare Equity Capital Markets on What IO Biotechs Can Expect in 2025
What work are you leading as Managing Director, Global Capital Markets at Morgan Stanley? My focus is meeting biotech companies early and following them through their life cycle as their funding needs ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Several Boston-area biotechs who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results